Finance

Lists
CAMX:STO
Camurus AB
SEK 738.50
-0.20%
(-1.50) 1D
Nov 17, 9:49:36 AM GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for CAMX...
Open
SEK 736.00
High
SEK 739.00
Low
SEK 734.50
Mkt. cap
45.12B
Avg. vol.
107.44K
Volume
17.94K
52-wk high
SEK 750.00
52-wk low
SEK 430.80
Shares outstanding
60.56M
No. of employees
323
Open
SEK 736.00
High
SEK 739.00
Low
SEK 734.50
Mkt. cap
45.12B
Avg. vol.
107.44K
Volume
17.94K
52-wk high
SEK 750.00
52-wk low
SEK 430.80
Shares outstanding
60.56M
No. of employees
323
News stories
From web sources and news partners
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap. Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB
CEOFredrik Tiberg
Employees323
Founded1991
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
464.46M
533.10M
702.08M
724.01M
Cost of goods sold
36.38M
37.16M
44.14M
46.35M
Cost of revenue
36.38M
37.16M
44.14M
46.35M
Research and development expenses
124.94M
137.61M
125.16M
141.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
184.49M
177.48M
232.32M
205.10M
Operating expense
304.07M
327.54M
365.44M
355.72M
Total operating expenses
340.45M
364.70M
409.58M
402.08M
Operating income
124.01M
168.40M
292.50M
321.93M
Other non operating income
-17.00K
-
-
-
EBT including unusual items
126.84M
183.86M
309.68M
340.54M
EBT excluding unusual items
126.80M
183.86M
309.68M
340.54M
Income tax expense
25.96M
40.04M
68.85M
70.55M
Effective tax rate
20.47%
21.78%
22.23%
20.72%
Other operating expenses
-5.36M
12.45M
7.95M
8.71M
Net income
100.88M
143.82M
240.83M
269.99M
Net profit margin
21.72%
26.98%
34.30%
37.29%
Earnings per share
1.67
2.40
4.05
4.53
Interest and investment income
15.54M
16.93M
18.60M
20.09M
Interest expense
-1.46M
-1.47M
-1.42M
-1.47M
Net interest expenses
14.08M
15.46M
17.18M
18.62M
Depreciation and amortization charges
-
-
-
-
EBITDA
130.67M
175.28M
299.63M
329.12M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps